Company · CIK 0001464521 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
Heartflow, Inc. · HTFL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 SForm 4 → | Sep 21, 6:19 pm EDT | Campbell RogersChief Medical Officer | 19,682 | $50.15 | $987,052 | 79,956 | −19.8% | 10b5-1 |
| Sep 18, 2026 MForm 4 → | Sep 21, 6:19 pm EDT | Campbell RogersChief Medical Officer | 13,179 | $7.94 | $104,588 | 99,638 | — | 10b5-1 |
| Sep 17, 2026 SForm 4 → | Sep 18, 8:46 pm EDT | Vikram VergheseChief Financial Officer | 24,345 | $50.55 | $1,230,742 | 155,183 | −13.6% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 15, 7:44 pm EDT | Vikram VergheseChief Financial Officer | 34,975 | $50.08 | $1,751,611 | 179,528 | −16.3% | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 14, 6:41 pm EDT | John C.M. FarquharChief Executive Officer, Director | 38,900 | $46.78 | $1,819,605 | 321,914 | −10.8% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 5:24 pm EDT | Vikram VergheseChief Financial Officer | 6,640 | $50.03 | $332,212 | 214,503 | −3.00% | 10b5-1 |
| Sep 2, 2026 SForm 4 → | Sep 4, 5:29 pm EDT | Vikram VergheseChief Financial Officer | 33,416 | $49.85 | $1,665,796 | 221,143 | −13.1% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 MForm 4 → | Sep 21, 6:19 pm EDT | Campbell RogersChief Medical Officer | 13,179 | — | — | 70,783 | — | 10b5-1 |